HIV-1 genetic variation and drug resistance development. - Wikidata - wikimedia - TriplyDB

HIV-1 genetic variation and drug resistance development.

HIV-1 genetic variation and drug resistance development.

http://www.wikidata.org/entity/Q30354857

about

Potential Antiviral Agents from Marine Fungi: An Overview Resistance analyses of integrase strand transfer inhibitors within phase 3 clinical trials of treatment-naive patients.The impact of wild-type reversion on transmitted resistance surveillance.Designer antigens for elicitation of broadly neutralizing antibodies against HIV.Potent in vitro antiviral activity of Cistus incanus extract against HIV and Filoviruses targets viral envelope proteins.Antifungal and antiviral products of marine organisms.Drug resistance in the HIV-1-infected paediatric population worldwide: a systematic review.HIV-1 Subtype Diversity and Prevalence of Primary Drug Resistance in a Single-Center Pediatric Cohort in Germany.Polyhydroxylated sulfated steroids derived from 5α-cholestanes as antiviral agents against herpes simplex virus.

P2860

Q26800107-AA067EE0-3C95-4DCA-891A-C93A2744F706 Q33963458-87426507-DFC9-4D1F-868C-54C13C8A71D0 Q34054047-3963A529-A948-4C6D-9745-FEFED7C83CD9 Q34511575-78D82473-D413-4658-991C-356A3B4478FF Q36528651-FCFD7867-A5D5-4782-94DC-895D0B7FBFA6 Q37634178-12108D07-89AE-48BC-B1F6-4CFC3FF6F156 Q38208721-D58C1506-4D96-46EC-9EF6-A8000163729F Q38694328-1F2503E7-DA07-458F-90E3-A5840B9A767C Q38776533-FC0925B2-A977-4A39-8698-9280CC873C8E

P2860

HIV-1 genetic variation and drug resistance development.

http://www.wikidata.org/entity/Q30354857

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

HIV-1 genetic variation and drug resistance development.

@ast

HIV-1 genetic variation and drug resistance development.

@en

type

label

HIV-1 genetic variation and drug resistance development.

@ast

HIV-1 genetic variation and drug resistance development.

@en

prefLabel

HIV-1 genetic variation and drug resistance development.

@ast

HIV-1 genetic variation and drug resistance development.

@en

P1433

Q30354857-D4BDE4CC-0494-4C2A-B194-63D7CCB96BAC

P1476

Q30354857-34FCB041-6D59-41DD-B2C1-04275884F7F5

P2093

Q30354857-91A1621C-91FF-48E3-87B6-6FE202F5212A

P2860

Q30354857-012BF9BF-CDF4-48A3-BE18-B56E7DA23DE7

Q30354857-02247D5A-D61E-4B39-B2DA-DF8B0FBA3A6B

Q30354857-030CDF45-A863-4A3A-8DB5-A5530FE41721

Q30354857-040E64AA-826D-4DDC-B9E4-04CD15ECD101

Q30354857-09A98B46-640E-4574-BC0D-47D14E422D9D

Q30354857-0A600898-2084-4F52-8D31-DAF8A117A67F

Q30354857-0BA5261C-DEA8-4F2E-B0FE-D595289D8061

Q30354857-0C300037-C325-42BA-9317-C8832C2999CF

Q30354857-131200B7-0851-42B9-AEA2-A7DE5376BC6B

Q30354857-1653DA44-2C58-4A43-A354-7A7A3D250A88

P304

Q30354857-C3FB0A72-8EFE-447A-A2CE-DDDCF59B0660

P31

Q30354857-CC21CDEC-3F1F-4981-AE53-E2F0FA9C43DC

P356

Q30354857-4065AFEE-83DA-424B-8173-50E53D62E82A

P433

Q30354857-1E38DB64-BB79-493E-BC7C-CC2ECB2BA6E8

P478

Q30354857-12B5D81E-A4DA-441E-A2C6-BF0E0B0B4323

P50

Q30354857-BABC574C-E6E1-4876-974F-85001E1CA037

P577

Q30354857-3D2B3DF2-196E-4D82-A3D7-C42E36979B29

P698

Q30354857-85ED7C38-C494-4B94-A513-907AE4BF8446

P356

14787210.2013.844649

P1433

Expert Review of Anti-infective Therapy

P1476

HIV-1 genetic variation and drug resistance development.

@en

P2093

Sarah Megens

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration

Polymorphism in Gag gene cleavage sites of HIV-1 non-B subtype and virological outcome of a first-line lopinavir/ritonavir single drug regimen

HIV-1 phenotypic reverse transcriptase inhibitor drug resistance test interpretation is not dependent on the subtype of the virus backbone

Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment Regimens

Global trends in molecular epidemiology of HIV-1 during 2000-2007.

Simian retroviruses in African apes.

Susceptibility to antiretroviral drugs of CRF01_AE, CRF02_AG, and subtype C viruses from untreated patients of Africa and Asia: comparative genotypic and phenotypic data.

Resistance profile of etravirine: combined analysis of baseline genotypic and phenotypic data from the randomized, controlled Phase III clinical studies.

Short communication: activity of etravirine on different HIV type 1 subtypes: in vitro susceptibility in treatment-naive patients and week 48 pooled DUET study data.

Combination of V106I and V179D polymorphic mutations in human immunodeficiency virus type 1 reverse transcriptase confers resistance to efavirenz and nevirapine but not etravirine.

P304

1159-1178

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14787210.2013.844649

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Kristel Van Laethem

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24151833

http://www.w3.org/2001/XMLSchema#string